Tech Company Financing Transactions
Paragon Bioservices Funding Round
Private investors participated in a $2 million Series A venture round for Paragon Bioservices. The round was announced on 8/18/2015.
Transaction Overview
Company Name
Announced On
8/18/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
801 W. Baltimore St. 302
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Website
Email Address
Not Recorded
Overview
Highly-flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective preclinical target validation services, process development and scale-up production of biopharmaceuticals for research purposes or Phase I/II clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Buzy
Chief Financial Officer
Gerard Fleury
Chief Information Officer
Dermot McCaul
Chief Scientific Officer
William Thomas
Vice President
George Buchman
VP - Bus. Development
Philip Wills
VP - Finance
Anne Shiflett
VP - Human Resources
Ruby Hofmann
VP - Manufacturing
John Conner
VP - Manufacturing
Randy Henrickson
VP - Regulatory Affairs
Deborah Wild
Browse more venture capital transactions:
Prev: 8/18/2015: HzO venture capital transaction
Next: 8/18/2015: Cignifi venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs